120517-52-4Relevant academic research and scientific papers
ACETYL-COA CARBOXYLASE MODULATORS
-
Paragraph 00251-00255, (2015/01/09)
Provided herein are compounds that exhibit activity as acetyl-CoA carboxylase modulators (e.g., inhibitors) and are useful, for example, in methods for the control of fungal pathogens in plants.
Synthesis and structures of (S)- and (R)-2-[3-cyano-4-(2-thienyl)-5,6,7, 8-tetrahydroquinolin-2-ylsulfanyl]-3-methyl-N-phenylbutyramide
Yao, Zhiyi,Du, Xiaojie,Liu, Hong,Jiang, Hualiang,Chen, Kaixian
, p. 3 - 5 (2007/10/03)
(S)- and (R)-2-[3-cyano-4-(2-thienyl)-5,6,7,8-tetrahydroquinolin-2- ylsulfanyl]-N-phenyl-3-methylbutyramide (1a and 1b) were prepared from 2-thiophenaldehyde and D- and L-valines, respectively, and their crystal structures were elucidated by X-ray crystallography.
SUBSTITUTED PYRIDO[3', 2': 4, 5]THIENO[3,2-D]PYRIMIDINES AND PYRIDO[3', 2': 4, 5]FURO[3, 2, D]PYRIMIDINES USED AS INHIBITORS OF THE PDE-4 AND/OR THE RELEASE OF TNFΓ(A)
-
Page/Page column 94-95, (2010/02/15)
The invention relates to compounds of general formula (I); 1a, 1 b, 1 c and 1 d. The invention also relates to a method for the production thereof, pharmaceutical preparations containing said compounds and/or physiologically compatible salts thereof which can be produced therefrom and/or solvates thereof, and to the pharmaceutical use of said compounds, salts or solvates thereof as inhibitors of phosphodiesterase 4. The compounds comprise active ingredients for the treatment of diseases which can have a positive influence by inhibiting the activity of phosphodiesterase 4 and/or TNFα-release, for example, in lymphocytes, eosinophile and basophile granulocytes, macrophages and mastocytes.
